Expression of beta-adrenergic receptor up-regulation is mediated by two different processes

Seitaro Ohkuma1, Masashi Katsura, Masahiro Shibasaki

  • 1Department of Pharmacology, Kawasaki Medical School, Kurashiki 701-0192, Japan. sohkuma@bcc.kawasaki-m.ac.jp

Brain Research
|August 22, 2006
PubMed

Insights

Sustained exposure to nadolol up-regulates beta-adrenergic receptors (beta-ARs) through two distinct mechanisms. These involve increased receptor protein translocation and, later, enhanced receptor protein and mRNA synthesis.

Area of Science:

  • Neuropharmacology
  • Molecular Biology
  • Cellular Neuroscience

Background:

  • Beta-adrenergic receptors (beta-ARs) play crucial roles in neuronal function.
  • Understanding receptor regulation is vital for developing targeted therapies.
  • Non-selective beta-AR antagonists like nadolol can induce adaptive changes in receptor expression.

Purpose of the Study:

  • To elucidate the mechanisms underlying beta-AR up-regulation induced by sustained nadolol exposure in mouse cerebrocortical neurons.
  • To differentiate between rapid and delayed responses in receptor expression and synthesis.

Main Methods:

  • Primary mouse cerebrocortical neuron cultures were exposed to nadolol (10(-8) M).
  • Quantification of [3H]CGP-12177 binding to measure beta-AR density.
  • Analysis of beta1- and beta2-AR mRNA levels.
  • Inhibition studies using cycloheximide (protein synthesis inhibitor) and Actinomycin D (mRNA synthesis inhibitor).
  • Western blot analysis to assess receptor protein translocation.

Main Results:

  • Nadolol dose- and time-dependently increased beta-AR binding, with a plateau at 12 hours.
  • Beta1- and beta2-AR mRNA levels increased significantly after 24 hours, plateauing at 3 days.
  • Scatchard analysis confirmed increased receptor density, not altered affinity.
  • Cycloheximide did not affect the magnitude of nadolol-induced binding increase, suggesting a component independent of new protein synthesis.
  • Actinomycin D inhibited the up-regulation when administered later, indicating a role for mRNA synthesis in the delayed response.
  • Increased receptor protein translocation from cytosol to membrane occurred within 24 hours.
  • Two distinct processes mediate up-regulation: rapid translocation and delayed synthesis-dependent mechanisms.

Conclusions:

  • Nadolol-induced beta-AR up-regulation involves at least two distinct pathways.
  • A rapid phase involves increased translocation of pre-existing receptor proteins.
  • A delayed phase depends on de novo receptor protein and mRNA synthesis.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...